Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari™ (L-glutamine oral powder)September 19, 2018 Read More
Emmaus Life Sciences, a Leader in Sickle Cell Disease Treatment, to Present at the Seventh Annual Sickle Cell Disease Therapeutics Conference in New York City on September 13thSeptember 11, 2018 Read More
Emmaus, a Leader in Sickle Cell Disease Treatment, Signs Agreement with McKesson to Expand Distribution Network for Endari™ (L-glutamine oral powder)August 27, 2018 Read More
Emmaus Life Sciences Partners with DMS Pharmaceutical Group to Provide Endari™ (L-glutamine oral powder) to Military Personnel and Beneficiaries for Treatment of Sickle Cell DiseaseJuly 30, 2018 Read More
